Oculis Holding AG - *W EXP 03/06/202 (OCSAW)

CUSIP: H5870P110

Q1 2026 13F Holders as of 31 Mar 2026

Share change
-31,719
SEC-reported price per share
$13.00
Number of holders
8
Value change
-$268,867
Number of buys
2
Number of sells
3

Security key

H5870P110

Report period

Q1 2026

Institutions

8

Top holders

8

Ownership snapshot

Top reported holders of OCSAW - Oculis Holding AG - *W EXP 03/06/202 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
7. Cooperative Ua Lsp
Disclosed value leader
7. Cooperative Ua Lsp
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G 13F Lead comparable stake: 12% 13D/G row: 7. Cooperative Ua Lsp Showing 1-6 of 15 holder rows.

Quick read

7. Cooperative Ua Lsp leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens 7. Cooperative Ua Lsp's linked filing trail.
Comparable ownership Top 5
7. Cooperative Ua Lsp 12%
Pivotal bioVenture Partners Fund ... 4.9%
BVCF IV, L.P. 4.1%
EQT Fund Management S.a r.l. 10%
Gildi - lifeyrissjodur 4.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
7. Cooperative Ua Lsp
13D/G
LSP 7 Cooperatieve U.A.
12%
$184,808,317
6,950,294 shares
+$31,838,866 31 Mar 2026
Pivotal bioVenture Partners Fund I, L.P.
13D/G
Nan Fung Group Holdings Limited
4.9%
$49,946,544
2,815,476 shares
$0 30 Sep 2025
BVCF IV, L.P.
13D/G
4.1%
$73,082,691
2,436,902 shares
+$7,350,309 13 Feb 2026
EQT Fund Management S.a r.l.
13F
Company
13F
10%
$117,828,871
5,900,294 shares
31 Dec 2025
Gildi - lifeyrissjodur
13F
Company
13F
4.2%
$50,250,171
2,447,985 shares
31 Dec 2025
Pivotal bioVenture Partners Investment Advisor LLC
13F
Company
13F
3.9%
$45,704,500
2,288,658 shares
31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
8
Shares
220,652
Rows available
8
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
10
Q1 2026 holders
8
Holder diff
-2
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .